[144] Atomera Incorporated SEC Filing

Rhea-AI Filing Summary

Atomera Incorporated (ATOM) filed a Form 144 notifying an intended sale of 3,601 common shares acquired by vesting of restricted stock on 09/01/2025. The broker listed is Morgan Stanley Smith Barney LLC and the approximate date of sale is 09/02/2025 on NASDAQ. The filing reports an aggregate market value of $11,381.34 for the shares to be sold and states the company has 31,482,756 shares outstanding. The filing also discloses two prior sales by Robert Mears in the past three months: 3,537 shares sold on 06/02/2025 for $21,229.36 and 4,196 shares sold on 06/11/2025 for $25,729.20. The filer affirms no undisclosed material adverse information and notes the securities were granted under an issuer equity compensation plan.

Insights

Securities Analyst

TL;DR: Routine insider disposition of recently vested restricted stock with modest market value relative to outstanding shares.

The Form 144 documents a planned sale of 3,601 shares received by vesting on 09/01/2025, to be executed through Morgan Stanley on NASDAQ. The disclosed aggregate market value is $11,381.34 against 31,482,756 shares outstanding, indicating the sale size is immaterial to total capitalization. The filing also records two recent June dispositions by Robert Mears totaling 7,733 shares for combined gross proceeds of $46,958.56. From a market-impact perspective, these volumes are small; the filing primarily serves regulatory compliance and transparency for insider liquidity events.

Corporate Governance Expert

TL;DR: The notice reflects standard reporting for equity compensation vesting and subsequent planned sale under Rule 144.

The filer states the shares were granted as part of an issuer equity compensation plan and were acquired by vesting on 09/01/2025. The signature representation affirms no material non-public information is known to the seller. The document includes past disposals by Robert Mears in June 2025, demonstrating ongoing insider liquidity. There is no indication in the filing of departures, plan amendments, or other governance actions; the filing reads as routine insider reporting required under securities rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3601	11381.34	31482756	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2025	Vesting of Restricted Stock	Issuer			3601	09/01/2025	Granted as part of an issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Mears 750 University Ave Suite 280 Los Gatos CA 95032	Common	06/02/2025	3537	21229.36
Robert Mears 750 University Ave Suite 280 Los Gatos CA 95032	Common	06/11/2025	4196	25729.20

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does Atomera (ATOM) plan to sell according to this Form 144?

The filer intends to sell 3,601 common shares acquired by vesting of restricted stock on 09/01/2025.

When and where is the planned sale expected to occur?

The approximate date of sale is 09/02/2025 and the securities exchange listed is NASDAQ via Morgan Stanley Smith Barney LLC.

What is the disclosed aggregate market value and total shares outstanding?

The aggregate market value of the shares to be sold is $11,381.34, and the filing lists 31,482,756 shares outstanding.

Were there any recent sales by the same person in the past three months?

Yes. Robert Mears sold 3,537 shares on 06/02/2025 for $21,229.36 and 4,196 shares on 06/11/2025 for $25,729.20.

How were the shares acquired that are being sold?

The shares were acquired by vesting of restricted stock and were granted as part of an issuer equity compensation plan.